WILMINGTON, Mass., Nov. 13, 2014 /PRNewswire/ -- Implant Sciences
Corporation (OTCQB: IMSC), a high technology supplier of systems
and sensors for homeland security and defense markets, announced
today that the U.S. Transportation Security Administration (TSA)
has placed an initial order for 1,170 QS-B220 Desktop Explosive
Trace Detectors and ancillary supplies. The systems will be
deployed at multiple airports across the country.
"Receiving this order from the TSA is a goal that Implant
Sciences has been driving towards for a number of years. Achieving
it is a major milestone for the Company and a tribute to the
ability and dedication of our employees. We are proud to help
protect the traveling public in the
United States and look forward to a long working
relationship with the TSA," stated Implant Sciences' CEO,
Glenn D. Bolduc.
About the QS-B220 Desktop Explosives Trace Detector
The QS-B220 uses Ion Mobility Spectrometry (IMS) to rapidly
detect and identify trace amounts of a wide variety of military,
commercial, and homemade explosives. Featuring a radioactive
material-free design, push-button maintenance and diagnostics, and
a patented inCal™ internal automatic calibration system, the
QS-B220 brings new levels of performance and convenience to desktop
trace detection users with unsurpassed ease of use.
About Implant Sciences
Implant Sciences is a leader in developing and manufacturing
advanced detection capabilities to counter and eliminate the
ever-evolving threats from explosives and drugs. The Company's team
of dedicated trace detection experts has developed proprietary
technologies used in its commercial products, thousands of which
have been sold across more than 50 countries worldwide. The
Company's ETDs have received approvals and certifications from
several international regulatory agencies including the TSA in the
U.S., STAC in France, the German
Ministry of the Interior, and the Ministry of Public Safety in
China. It also received a GSN 2013
Homeland Security Award for "Best Explosives Detection
Solution". All Implant Sciences products are recognized as
Qualified Anti-Terrorism Technologies by the Department of Homeland
Security. For further details on the Company and its products,
please visit the Company's website at www.implantsciences.com.
Safe Harbor Statement
This press release may contain certain "forward-looking
statements," as that term is defined in the Private Securities
Litigation Reform Act of 1995. Such statements are based on
management's current expectations and are subject to risks and
uncertainties that could cause the Company's actual results to
differ materially from the forward-looking statements. Such risks
and uncertainties include, but are not limited to, the risks that
there is no guaranty that U.S. or foreign government and law
enforcement agencies or commercial consumers will purchase any of
our explosives detection products or that any new products we may
develop will be accepted by the TSA or by such other governments,
agencies or consumers; economic, political and other risks
associated with international sales and operations could adversely
affect our sales; our business is subject to intense competition
and rapid technological change, and our success will depend on our
ability to develop and introduce new products; and other risks and
uncertainties described in our filings with the Securities and
Exchange Commission, including our most recent Forms 10-K, 10-Q and
8-K. Such statements are based on management's current expectations
and assumptions which could differ materially from the
forward-looking statements.
SOURCE Implant Sciences Corporation